Published in BMJ Case Rep on December 05, 2013
Post-Liver Transplant Delirium Increases Mortality and Length of Stay. Ochsner J (2017) 0.75
Neurological Complications after Renal Transplantation: A Retrospective Clinical Study. Noro Psikiyatr Ars (2015) 0.75
Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int (2000) 2.43
Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation (2000) 1.62
Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients 2010 data report. Am J Transplant (2011) 1.46
Neurologic complications of FK 506. Transplant Proc (1991) 1.34
Neurotoxicity of immunosuppressive drugs. Liver Transpl (2001) 1.24
FK506-induced neurotoxicity in liver transplantation. Ann Neurol (1994) 1.16
Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation. BMC Nephrol (2006) 1.15
Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve (1994) 0.94
Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. Am J Transplant (2013) 0.92
Recovery of tacrolimus-associated brachial neuritis after conversion to everolimus in a pediatric renal transplant recipient--case report and review of the literature. Pediatr Transplant (2008) 0.92
Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc (2005) 0.91
Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: case reports. Transplant Proc (2007) 0.87
Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. Transplantation (2000) 0.84
Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient. J Heart Lung Transplant (2007) 0.83
Peripheral neurotoxicity with tacrolimus. Lancet (1994) 0.82
Neurotoxicity in the setting of pediatric atopic dermatitis treated with modified cyclosporine and itraconazole. J Am Acad Dermatol (2013) 0.81
Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc (1991) 0.81
Interaction between tacrolimus and nefazodone in a stable renal transplant recipient. Pharmacotherapy (1999) 0.78
Ionizing radiation exposure among kidney transplant recipients due to medical imaging during the pretransplant evaluation. Clin J Am Soc Nephrol (2013) 1.45
Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42
Preimplant histologic acute tubular necrosis and allograft outcomes. Clin J Am Soc Nephrol (2014) 1.04
Improving the delivery of patient education about kidney transplant in a transplant center. Prog Transplant (2012) 0.84
Electronically measured adherence to immunosuppressive medications and kidney function after deceased donor kidney transplantation. Clin Transplant (2010) 0.75
Utility of applying quality assessment tools for kidneys with KDPI ≥80. Transplantation (2016) 0.75
Delayed graft function phenotypes and 12-month kidney transplant outcomes. Transplantation (2016) 0.75
Urine injury biomarkers are not associated with kidney transplant failure. Transplantation (2019) 0.75